9999999995-14-000828.txt : 20140401 9999999995-14-000828.hdr.sgml : 20140401 20140401001512 ACCESSION NUMBER: 9999999995-14-000828 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140331 DATE AS OF CHANGE: 20140401 EFFECTIVENESS DATE: 20140331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Celsus Therapeutics Plc. CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-187826 FILM NUMBER: 14732179 BUSINESS ADDRESS: STREET 1: 53 DAVIES STREET CITY: LONDON STATE: X0 ZIP: W1K 5JH BUSINESS PHONE: 646-878-0804 MAIL ADDRESS: STREET 1: C/O MARK COHEN, CHAIRMAN, PEARL COHEN STREET 2: 1500 BROADWAY, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2014-03-31 0001144204-14-015394 POS AM 0001541157 Celsus Therapeutics Plc. 333-187826